Conditions: Acute Gouty Arthritis
Keywords: Gout arthritis gout flare acute gout gouty rheumatic disease uric acid podagra
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 397
Healthy volunteers: no

Brief summary:
This is a 36 week open-label extension of the canakinumab pre-filled syringe study for safety and tolerability in patients who have frequent flares of acute gouty arthritis.

Detailed description:

Arms:
arm 1: Canakinumab 150mg in prefilled syringe subcutaneously

Interventions: intervention 1: Canakinumab 150mg in prefilled syringe
Intervention descriptions: intervention 1: Canakinumab 150mg in prefilled syringe will be given in a single dose subcutaneously upon demand for gouty arthritis flares

Protocol document: